AI assistant
Sending…
Cigna Group — Director's Dealing 2022
Sep 6, 2022
29918_dirs_2022-09-06_a4567858-5646-415d-a404-cfb2efa45964.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2022-09-01
Reporting Person: BRAILER DAVID J (EVP & Chief Health Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-01 | Common Stock, $.01 Par Value | A | 1749.0000 | $0.0000 | Acquired | 1749.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-01 | Employee Stock Option (Right to Buy) | $285.9700 | A | 7841.0000 | Acquired | 2032-09-01 | Common Stock, $.01 Par Value (7841.0000) | Direct |
Footnotes
F1: These restricted shares vest in three equal annual installments beginning September 1, 2023.
F2: This option vests in three equal annual installments beginning September 1, 2023.
More from Cigna Group
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4